T1	Participants 506 676	all participants had sterile cultures of cerebrospinal fluid, blood, and urine after following a standardized course of therapy for culture-proved cryptococcal meningitis
T2	Participants 67 151	after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome
T3	Participants 894 924	84 patients initially enrolled
